Keurig Dr Pepper Reports Q2 2023 Results, Raises Full Year Net Sales Outlook and Reaffirms EPS Guidance
- Q2 net sales increased by 6.6% to $3.79 billion.
- Full-year net sales outlook raised to 5% to 6%.
- Adjusted diluted EPS growth guidance remains at 6% to 7%.
- None.
Strong Q2 Net Sales Growth Led by
Full Year Net Sales Outlook Increased to
BURLINGTON, Mass. and FRISCO, Texas , July 27, 2023 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today reported results for the second quarter ended June 30, 2023, raised its full year constant currency net sales growth outlook to
Reported GAAP Basis | Adjusted Basis1 | |||||||
Q2 | YTD | Q2 | YTD | |||||
Net Sales | ||||||||
% vs prior year | 6.6 % | 7.7 % | 6.1 % | 7.4 % | ||||
Diluted EPS | ||||||||
% vs prior year | 140.0 % | 23.2 % | 7.7 % | 5.6 % |
Commenting on the announcement, Chairman and CEO Bob Gamgort stated, "Our second quarter results demonstrated the strength of KDP's brand portfolio and our high-quality retail execution. We saw continued momentum in the
Second Quarter Consolidated Results
Net sales for the second quarter of 2023 increased
KDP in-market performance in the
GAAP operating income increased
Excluding items affecting comparability, Adjusted operating income increased
GAAP net income for the quarter increased
Free cash flow for the second quarter was
During the quarter, the Company repurchased approximately 7 million KDP shares at a weighted average price per share of
_________________________________________ |
1 Adjusted financial metrics presented in this release are non-GAAP and with growth rates presented on a constant currency basis. See reconciliations of GAAP results to Adjusted results on a constant currency basis in the accompanying tables. |
Second Quarter Segment Results
Net sales for the second quarter increased
GAAP operating income increased a very strong
Net sales for the second quarter decreased
At-home coffee consumption in the quarter continued to be impacted by year-over-year changes in mobility, with sequential improvement in category volume trends observable each month of the quarter. Pod revenue declined
Brewer shipments totaled 9.9 million for the twelve months ending June 30, 2023, representing an
GAAP operating income decreased
International
Net sales for the second quarter increased
GAAP operating income increased a strong
2023 Guidance
The 2023 guidance provided below is presented on a constant currency, non-GAAP basis. The Company does not provide reconciliations of such forward-looking non-GAAP measures to GAAP measures, due to the inability to predict the amount and timing of impacts outside of the Company's control on certain items, such as non-cash gains or losses resulting from mark-to-market adjustments of derivative instruments, among others, which could be material.
On a constant currency basis, KDP now expects net sales growth of
Investor Contacts:
Jane Gelfand
T: 888-340-5287 / jane.gelfand@kdrp.com
Chethan Mallela
T: 888-340-5287 / chethan.mallela@kdrp.com
Media Contact:
Katie Gilroy
T: 781-418-3345 / katie.gilroy@kdrp.com
ABOUT KEURIG DR PEPPER
Keurig Dr Pepper (KDP) is a leading beverage company in
FORWARD LOOKING STATEMENTS
Certain statements contained herein are "forward-looking statements" within the meaning of applicable securities laws and regulations. These forward-looking statements can generally be identified by the use of words such as "outlook," "guidance," "anticipate," "expect," "believe," "could," "estimate," "feel," "forecast," "intend," "may," "plan," "potential," "project," "should," "target," "will," "would," and similar words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. These statements are based on the current expectations of our management, are not predictions of actual performance, and actual results may differ materially.
Forward-looking statements are subject to a number of risks and uncertainties, including the factors disclosed in our Annual Report on Form 10-K and subsequent filings with the SEC. We are under no obligation to update, modify or withdraw any forward-looking statements, except as required by applicable law.
NON-GAAP FINANCIAL MEASURES
This release includes certain non-GAAP financial measures including Adjusted gross profit, Adjusted operating income, Adjusted net income, Adjusted diluted EPS, free cash flow and financial measures presented on a constant currency basis, which differ from results using
To the extent that the Company provides guidance, it does so only on a non-GAAP basis and does not provide reconciliations of such forward-looking non-GAAP measures to GAAP due to the inability to predict the amount and timing of impacts outside of the Company's control on certain items, such as non-cash gains or losses resulting from mark-to-market adjustments of derivative instruments, among others, which could be material.
KEURIG DR PEPPER INC. | |||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||
(UNAUDITED) | |||||||
Second Quarter | First Six Months | ||||||
(in millions, except per share data) | 2023 | 2022 | 2023 | 2022 | |||
Net sales | $ 3,789 | $ 3,554 | $ 7,142 | $ 6,632 | |||
Cost of sales | 1,748 | 1,778 | 3,357 | 3,206 | |||
Gross profit | 2,041 | 1,776 | 3,785 | 3,426 | |||
Selling, general and administrative expenses | 1,272 | 1,204 | 2,437 | 2,222 | |||
Gain on litigation settlement | — | — | — | (299) | |||
Other operating income, net | — | — | (5) | (35) | |||
Income from operations | 769 | 572 | 1,353 | 1,538 | |||
Interest expense | 172 | 175 | 195 | 363 | |||
Loss on early extinguishment of debt | — | 169 | — | 217 | |||
Gain on sale of equity method investment | — | — | — | (50) | |||
Impairment of investments and note receivable | — | 6 | — | 12 | |||
Other (income) expense, net | (16) | 9 | (36) | 18 | |||
Income before provision for income taxes | 613 | 213 | 1,194 | 978 | |||
Provision (benefit) for income taxes | 110 | (5) | 224 | 175 | |||
Net income including non-controlling interest | 503 | 218 | 970 | 803 | |||
Less: Net loss attributable to non-controlling interest | — | — | — | — | |||
Net income attributable to KDP | $ 503 | $ 218 | $ 970 | $ 803 | |||
Earnings per common share: | |||||||
Basic | $ 0.36 | $ 0.15 | $ 0.69 | $ 0.57 | |||
Diluted | 0.36 | 0.15 | 0.69 | 0.56 | |||
Weighted average common shares outstanding: | |||||||
Basic | 1,400.3 | 1,417.5 | 1,403.2 | 1,417.8 | |||
Diluted | 1,409.1 | 1,428.6 | 1,413.1 | 1,429.2 |
KEURIG DR PEPPER INC. | |||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||
(UNAUDITED) | |||
June 30, | December 31, | ||
(in millions, except share and per share data) | 2023 | 2022 | |
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ 278 | $ 535 | |
Trade accounts receivable, net | 1,311 | 1,484 | |
Inventories | 1,384 | 1,314 | |
Prepaid expenses and other current assets | 597 | 471 | |
Total current assets | 3,570 | 3,804 | |
Property, plant and equipment, net | 2,489 | 2,491 | |
Investments in unconsolidated affiliates | 1,019 | 1,000 | |
Goodwill | 20,194 | 20,072 | |
Other intangible assets, net | 23,344 | 23,183 | |
Other non-current assets | 1,153 | 1,252 | |
Deferred tax assets | 32 | 35 | |
Total assets | $ 51,801 | $ 51,837 | |
Liabilities and Stockholders' Equity | |||
Current liabilities: | |||
Accounts payable | 4,601 | 5,206 | |
Accrued expenses | 1,030 | 1,153 | |
Structured payables | 126 | 137 | |
Short-term borrowings and current portion of long-term obligations | 2,635 | 895 | |
Other current liabilities | 664 | 685 | |
Total current liabilities | 9,056 | 8,076 | |
Long-term obligations | 9,934 | 11,072 | |
Deferred tax liabilities | 5,736 | 5,739 | |
Other non-current liabilities | 1,808 | 1,825 | |
Total liabilities | 26,534 | 26,712 | |
Commitments and contingencies | |||
Stockholders' equity: | |||
Preferred stock, | — | — | |
Common stock, | 14 | 14 | |
Additional paid-in capital | 21,009 | 21,444 | |
Retained earnings | 3,948 | 3,539 | |
Accumulated other comprehensive income | 297 | 129 | |
Total stockholders' equity | 25,268 | 25,126 | |
Non-controlling interest | (1) | (1) | |
Total equity | 25,267 | 25,125 | |
Total liabilities and stockholders' equity | $ 51,801 | $ 51,837 |
KEURIG DR PEPPER INC. | ||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||
(UNAUDITED) | ||||
First Six Months | ||||
(in millions) | 2023 | 2022 | ||
Operating activities: | ||||
Net income attributable to KDP | $ 970 | $ 803 | ||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||
Depreciation expense | 201 | 205 | ||
Amortization of intangibles | 69 | 67 | ||
Other amortization expense | 91 | 86 | ||
Provision for sales returns | 26 | 25 | ||
Deferred income taxes | (26) | (52) | ||
Employee stock-based compensation expense | 57 | 12 | ||
Loss on early extinguishment of debt | — | 217 | ||
Gain on sale of equity method investment | — | (50) | ||
Gain on disposal of property, plant and equipment | (2) | (33) | ||
Unrealized (gain) loss on foreign currency | (13) | 2 | ||
Unrealized (gain) loss on derivatives | (31) | 187 | ||
Settlements of interest rate contracts | — | 125 | ||
Equity in (earnings) loss of unconsolidated affiliates | (14) | 5 | ||
Impairment on investments and note receivable of unconsolidated affiliates | — | 12 | ||
Other, net | (9) | 22 | ||
Changes in assets and liabilities: | ||||
Trade accounts receivable | 162 | (206) | ||
Inventories | (61) | (346) | ||
Income taxes receivable and payables, net | (70) | (245) | ||
Other current and non-current assets | (147) | (340) | ||
Accounts payable and accrued expenses | (762) | 680 | ||
Other current and non-current liabilities | 11 | 163 | ||
Net change in operating assets and liabilities | (867) | (294) | ||
Net cash provided by operating activities | 452 | 1,339 | ||
Investing activities: | ||||
Proceeds from sale of investment in unconsolidated affiliates | — | 50 | ||
Purchases of property, plant and equipment | (149) | (186) | ||
Proceeds from sales of property, plant and equipment | 8 | 78 | ||
Purchases of intangibles | (55) | (10) | ||
Issuance of related party note receivable | — | (18) | ||
Investments in unconsolidated affiliates | (8) | (48) | ||
Other, net | 1 | 3 | ||
Net cash (used in) provided by investing activities | (203) | (131) | ||
Financing activities: | ||||
Proceeds from issuance of Notes | — | 3,000 | ||
Repayments of Notes | — | (3,365) | ||
Proceeds from issuance of commercial paper | 18,187 | 500 | ||
Repayments of commercial paper | (17,598) | (649) | ||
Proceeds from structured payables | 61 | 79 | ||
Repayments of structured payables | (72) | (75) | ||
Cash dividends paid | (563) | (531) | ||
Repurchases of common stock | (457) | (88) | ||
Tax withholdings related to net share settlements | (32) | (8) | ||
Payments on finance leases | (49) | (41) | ||
Other, net | — | (43) | ||
Net cash used in financing activities | (523) | (1,221) | ||
Cash, cash equivalents, and restricted cash and cash equivalents: | ||||
Net change from operating, investing and financing activities | (274) | (13) | ||
Effect of exchange rate changes | 17 | (1) | ||
Beginning balance | 535 | 568 | ||
Ending balance | $ 278 | $ 554 |
KEURIG DR PEPPER INC. | |||||||
RECONCILIATION OF SEGMENT INFORMATION | |||||||
(UNAUDITED) | |||||||
Second Quarter | First Six Months | ||||||
(in millions) | 2023 | 2022 | 2023 | 2022 | |||
Net Sales | |||||||
$ 2,330 | $ 2,084 | $ 4,337 | $ 3,865 | ||||
970 | 1,029 | 1,901 | 1,972 | ||||
International | 489 | 441 | 904 | 795 | |||
Total net sales | $ 3,789 | $ 3,554 | $ 7,142 | $ 6,632 | |||
Income from Operations | |||||||
$ 629 | $ 528 | $ 1,119 | $ 1,232 | ||||
250 | 295 | 482 | 550 | ||||
International | 112 | 98 | 192 | 162 | |||
Unallocated corporate costs | (222) | (349) | (440) | (406) | |||
Total income from operations | $ 769 | $ 572 | $ 1,353 | $ 1,538 |
KEURIG DR PEPPER INC.
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION
(UNAUDITED)
The company reports its financial results in accordance with
Specifically, investors should consider the following with respect to our financial results:
Adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability.
Items affecting comparability: Defined as certain items that are excluded for comparison to prior year periods, adjusted for the tax impact as applicable. Tax impact is determined based upon an approximate rate for each item. For each period, management adjusts for (i) the unrealized mark-to-market impact of derivative instruments not designated as hedges in accordance with
For the second quarter and first six months of 2023, the other certain items excluded for comparison purposes include (i) productivity expenses and (ii) costs related to significant non-routine legal matters, specifically the antitrust litigation. Additionally, the non-cash changes in deferred tax liabilities related to goodwill and other intangible assets included an immaterial correction of an error during the second quarter of 2023 related to the valuation of the foreign deferred tax liabilities related to goodwill and other intangible assets.
For the second quarter and first six months of 2022, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) costs related to significant non-routine legal matters, specifically the antitrust litigation; (iv) the loss on early extinguishment of debt related to the redemption of debt; (v) incremental costs to our operations related to risks associated with the COVID-19 pandemic, which were incurred to either maintain the health and safety of our front-line employees or temporarily increase compensation to such employees to ensure essential operations continue during the pandemic; (vi) the gain on the sale of our investment in BodyArmor as a result of the settlement of the associated holdback liability; (vii) the gain on the settlement of our prior litigation with BodyArmor, excluding recoveries of previously incurred litigation expenses which were included in our adjusted results; (viii) losses recognized with respect to our equity method investment in Bedford as a result of funding our share of their wind-down costs; (ix) transaction costs for significant business combinations (completed or abandoned); and (x) foundational projects, which are transformative and non-recurring in nature.
Constant currency adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability, calculated on a constant currency basis by converting our current period local currency financial results using the prior period foreign currency exchange rates.
For the second quarter and first six months of 2023 and 2022, the supplemental financial data set forth below includes reconciliations of adjusted and constant currency adjusted financial measures to the applicable financial measure presented in the unaudited condensed consolidated financial statements for the same period.
KEURIG DR PEPPER INC. | |||||||||||||
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION | |||||||||||||
(UNAUDITED) | |||||||||||||
Cost of | Gross profit | Gross | Selling, general and | Other | Income | Operating | |||||||
For the Second Quarter of 2023 | |||||||||||||
Reported | $ 1,748 | $ 2,041 | 53.9 % | $ 1,272 | $ — | $ 769 | 20.3 % | ||||||
Items Affecting Comparability: | |||||||||||||
Mark to market | (9) | 9 | 5 | — | 4 | ||||||||
Amortization of intangibles | — | — | (35) | — | 35 | ||||||||
Stock compensation | — | — | (4) | — | 4 | ||||||||
Productivity | (26) | 26 | (32) | — | 58 | ||||||||
Non-routine legal matters | — | — | (3) | — | 3 | ||||||||
Adjusted | $ 1,713 | $ 2,076 | 54.8 % | $ 1,203 | $ — | $ 873 | 23.0 % | ||||||
Impact of foreign currency | (0.1) % | — % | |||||||||||
Constant currency adjusted | 54.7 % | 23.0 % | |||||||||||
For the Second Quarter of 2022 | |||||||||||||
Reported | $ 1,778 | $ 1,776 | 50.0 % | $ 1,204 | $ — | $ 572 | 16.1 % | ||||||
Items Affecting Comparability: | |||||||||||||
Mark to market | (138) | 138 | — | — | 138 | ||||||||
Amortization of intangibles | — | — | (33) | — | 33 | ||||||||
Stock compensation | — | — | (5) | — | 5 | ||||||||
Restructuring and integration costs | — | — | (23) | 1 | 22 | ||||||||
Productivity | (28) | 28 | (24) | — | 52 | ||||||||
Non-routine legal matters | — | — | (3) | — | 3 | ||||||||
COVID-19 | (3) | 3 | (1) | — | 4 | ||||||||
Transaction costs | — | — | (1) | — | 1 | ||||||||
Foundational projects | — | — | (2) | — | 2 | ||||||||
Adjusted | $ 1,609 | $ 1,945 | 54.7 % | $ 1,112 | $ 1 | $ 832 | 23.4 % |
Refer to page A-8 for reconciliations of reported net sales to constant currency net sales and adjusted income from operations to constant currency adjusted income from operations. |
KEURIG DR PEPPER INC. | |||||||||||||||||
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION | |||||||||||||||||
(UNAUDITED) | |||||||||||||||||
Interest | Loss on early | Impairment of | Other | Income before | Provision | Effective | Net income | Diluted | |||||||||
For the Second Quarter of 2023 | |||||||||||||||||
Reported | $ 172 | $ — | $ — | $ (16) | $ 613 | $ 110 | 17.9 % | $ 503 | $ 0.36 | ||||||||
Items Affecting Comparability: | |||||||||||||||||
Mark to market | (53) | — | — | 9 | 48 | 15 | 33 | 0.02 | |||||||||
Amortization of intangibles | — | — | — | — | 35 | 6 | 29 | 0.02 | |||||||||
Amortization of deferred financing costs | (1) | — | — | — | 1 | — | 1 | — | |||||||||
Amortization of fair value debt adjustment | (5) | — | — | — | 5 | 1 | 4 | — | |||||||||
Stock compensation | — | — | — | — | 4 | 1 | 3 | — | |||||||||
Productivity | — | — | — | — | 58 | 12 | 46 | 0.03 | |||||||||
Non-routine legal matters | — | — | — | — | 3 | 1 | 2 | — | |||||||||
Change in deferred tax liabilities related to | — | — | — | — | — | 25 | (25) | (0.02) | |||||||||
Adjusted | $ 113 | $ — | $ — | $ (7) | $ 767 | $ 171 | 22.3 % | $ 596 | $ 0.42 | ||||||||
Impact of foreign currency | (0.2) % | ||||||||||||||||
Constant currency adjusted | 22.1 % | ||||||||||||||||
For the Second Quarter of 2022 | |||||||||||||||||
Reported | $ 175 | $ 169 | $ 6 | $ 9 | $ 213 | $ (5) | (2.3) % | $ 218 | $ 0.15 | ||||||||
Items Affecting Comparability: | |||||||||||||||||
Mark to market | (63) | — | — | 1 | 200 | 49 | 151 | 0.11 | |||||||||
Amortization of intangibles | — | — | — | — | 33 | 8 | 25 | 0.02 | |||||||||
Amortization of deferred financing costs | (1) | — | — | — | 1 | — | 1 | — | |||||||||
Amortization of fair value of debt adjustment | (4) | — | — | — | 4 | 1 | 3 | — | |||||||||
Stock compensation | — | — | — | — | 5 | (2) | 7 | — | |||||||||
Restructuring and integration costs | — | — | — | — | 22 | 5 | 17 | 0.01 | |||||||||
Productivity | — | — | — | — | 52 | 10 | 42 | 0.03 | |||||||||
Impairment of investment | — | — | (6) | — | 6 | — | 6 | — | |||||||||
Loss on early extinguishment of debt | — | (169) | — | — | 169 | 43 | 126 | 0.09 | |||||||||
Non-routine legal matters | — | — | — | — | 3 | 1 | 2 | — | |||||||||
COVID-19 | — | — | — | — | 4 | 1 | 3 | — | |||||||||
Transaction costs | — | — | — | — | 1 | — | 1 | — | |||||||||
Foundational projects | — | — | — | — | 2 | — | 2 | — | |||||||||
Change in deferred tax liabilities related to | — | — | — | — | — | 50 | (50) | (0.03) | |||||||||
Adjusted | $ 107 | $ — | $ — | $ 10 | $ 715 | $ 161 | 22.5 % | $ 554 | $ 0.39 | ||||||||
Change - adjusted | 5.6 % | 7.6 % | 7.7 % | ||||||||||||||
Impact of foreign currency | — % | (0.6) % | — % | ||||||||||||||
Change - constant currency adjusted | 5.6 % | 7.0 % | 7.7 % |
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION | |||||
(UNAUDITED) | |||||
(in millions) | Reported | Items Affecting | Adjusted | ||
For the second quarter of 2023 | |||||
Income from operations | |||||
$ 629 | $ 17 | $ 646 | |||
250 | 42 | 292 | |||
International | 112 | 4 | 116 | ||
Unallocated corporate costs | (222) | 41 | (181) | ||
Total income from operations | $ 769 | $ 104 | $ 873 | ||
For the second quarter of 2022 | |||||
Income from operations | |||||
$ 528 | $ 19 | $ 547 | |||
295 | 47 | 342 | |||
International | 98 | 6 | 104 | ||
Unallocated corporate costs | (349) | 188 | (161) | ||
Total income from operations | $ 572 | $ 260 | $ 832 |
Reported | Impact of Foreign | Constant Currency | ||||
For the second quarter of 2023 | ||||||
Net sales | ||||||
11.8 % | — % | 11.8 % | ||||
(5.7) | — | (5.7) | ||||
International | 10.9 | (3.9) | 7.0 | |||
Total net sales | 6.6 | (0.5) | 6.1 |
Adjusted | Impact of Foreign | Constant Currency | ||||
For the second quarter of 2023 | ||||||
Income from operations | ||||||
18.1 % | — % | 18.1 % | ||||
(14.6) | — | (14.6) | ||||
International | 11.5 | (3.8) | 7.7 | |||
Total income from operations | 4.9 | (0.5) | 4.4 |
Reported | Items Affecting | Adjusted | Impact of | Constant | ||||||
For the second quarter of 2023 | ||||||||||
Operating margin | ||||||||||
27.0 % | 0.7 % | 27.7 % | — % | 27.7 % | ||||||
25.8 | 4.3 | 30.1 | — | 30.1 | ||||||
International | 22.9 | 0.8 | 23.7 | — | 23.7 | |||||
Total operating margin | 20.3 | 2.7 | 23.0 | — | 23.0 |
KEURIG DR PEPPER INC. | |||||||||||||||
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION | |||||||||||||||
(UNAUDITED) | |||||||||||||||
Cost of sales | Gross profit | Gross | Selling, general | Gain on | Other operating | Income from | Operating | ||||||||
For the First Six Months of 2023 | |||||||||||||||
Reported | $ 3,357 | $ 3,785 | 53.0 % | $ 2,437 | $ — | $ (5) | $ 1,353 | 18.9 % | |||||||
Items Affecting Comparability: | |||||||||||||||
Mark to market | 5 | (5) | (7) | — | — | 2 | |||||||||
Amortization of intangibles | — | — | (69) | — | — | 69 | |||||||||
Stock compensation | — | — | (9) | — | — | 9 | |||||||||
Productivity | (64) | 64 | (72) | — | — | 136 | |||||||||
Non-routine legal matters | — | — | (3) | — | — | 3 | |||||||||
Adjusted | $ 3,298 | $ 3,844 | 53.8 % | $ 2,277 | $ — | $ (5) | $ 1,572 | 22.0 % | |||||||
Impact of foreign currency | — % | — % | |||||||||||||
Constant currency adjusted | 53.8 % | 22.0 % | |||||||||||||
For the First Six Months of 2022 | |||||||||||||||
Reported | $ 3,206 | $ 3,426 | 51.7 % | $ 2,222 | $ (299) | $ (35) | $ 1,538 | 23.2 % | |||||||
Items Affecting Comparability: | |||||||||||||||
Mark to market | (79) | 79 | 26 | — | — | 53 | |||||||||
Amortization of intangibles | — | — | (67) | — | — | 67 | |||||||||
Stock compensation | — | — | 2 | — | — | (2) | |||||||||
Restructuring and integration costs | — | — | (56) | — | (2) | 58 | |||||||||
Productivity | (56) | 56 | (46) | — | — | 102 | |||||||||
Non-routine legal matters | — | — | (7) | — | — | 7 | |||||||||
COVID-19 | (7) | 7 | (2) | — | — | 9 | |||||||||
Gain on litigation | — | — | — | 271 | — | (271) | |||||||||
Transaction costs | — | — | (1) | — | — | 1 | |||||||||
Foundational projects | — | — | (2) | — | — | 2 | |||||||||
Adjusted | $ 3,064 | $ 3,568 | 53.8 % | $ 2,069 | $ (28) | $ (37) | $ 1,564 | 23.6 % |
Refer to page A-11 for reconciliations of reported net sales to constant currency net sales and adjusted income from operations to constant currency adjusted income from operations. |
KEURIG DR PEPPER INC. | |||||||||||||||||||
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION | |||||||||||||||||||
(UNAUDITED) | |||||||||||||||||||
Interest | Loss on early | Gain on sale of | Impairment of | Other | Income before | Provision | Effective | Net income | Diluted | ||||||||||
For the First Six Months of 2023 | |||||||||||||||||||
Reported | $ 195 | $ — | $ — | $ — | $ (36) | $ 1,194 | $ 224 | 18.8 % | $ 970 | $ 0.69 | |||||||||
Items Affecting Comparability: | |||||||||||||||||||
Mark to market | 40 | — | — | — | 18 | (56) | (14) | (42) | (0.03) | ||||||||||
Amortization of intangibles | — | — | — | — | — | 69 | 16 | 53 | 0.04 | ||||||||||
Amortization of deferred financing costs | (1) | — | — | — | — | 1 | — | 1 | — | ||||||||||
Amortization of fair value debt adjustment | (9) | — | — | — | — | 9 | 2 | 7 | 0.01 | ||||||||||
Stock compensation | — | — | — | — | — | 9 | 3 | 6 | — | ||||||||||
Productivity | — | — | — | — | — | 136 | 33 | 103 | 0.07 | ||||||||||
Non-routine legal matters | — | — | — | — | — | 3 | 1 | 2 | — | ||||||||||
Change in deferred tax liabilities related to | — | — | — | — | — | — | 25 | (25) | (0.02) | ||||||||||
Adjusted | $ 225 | $ — | $ — | $ — | $ (18) | $ 1,365 | $ 290 | 21.2 % | $ 1,075 | $ 0.76 | |||||||||
Impact of foreign currency | 0.1 % | ||||||||||||||||||
Constant currency adjusted | 21.3 % | ||||||||||||||||||
For the First Six Months of 2022 | |||||||||||||||||||
Reported | $ 363 | $ 217 | $ (50) | $ 12 | $ 18 | $ 978 | $ 175 | 17.9 % | $ 803 | $ 0.56 | |||||||||
Items Affecting Comparability: | |||||||||||||||||||
Mark to market | (134) | — | — | — | (2) | 189 | 47 | 142 | 0.10 | ||||||||||
Amortization of intangibles | — | — | — | — | — | 67 | 17 | 50 | 0.04 | ||||||||||
Amortization of deferred financing costs | (2) | — | — | — | — | 2 | — | 2 | — | ||||||||||
Amortization of fair value of debt adjustment | (9) | — | — | — | — | 9 | 2 | 7 | — | ||||||||||
Stock compensation | — | — | — | — | — | (2) | (3) | 1 | — | ||||||||||
Restructuring and integration costs | — | — | — | — | — | 58 | 14 | 44 | 0.03 | ||||||||||
Productivity | — | — | — | — | — | 102 | 22 | 80 | 0.06 | ||||||||||
Impairment of investment | — | — | — | (12) | — | 12 | — | 12 | — | ||||||||||
Loss on early extinguishment of debt | — | (217) | — | — | — | 217 | 54 | 163 | 0.12 | ||||||||||
Non-routine legal matters | — | — | — | — | — | 7 | 2 | 5 | — | ||||||||||
COVID-19 | — | — | — | — | — | 9 | 2 | 7 | — | ||||||||||
Gain on litigation | — | — | — | — | — | (271) | (68) | (203) | (0.14) | ||||||||||
Gain on sale of equity-method investment | — | — | 50 | — | — | (50) | (12) | (38) | (0.03) | ||||||||||
Transaction costs | — | — | — | — | — | 1 | — | 1 | — | ||||||||||
Foundational projects | — | — | — | — | — | 2 | — | 2 | — | ||||||||||
Change in deferred tax liabilities related to | — | — | — | — | — | — | 50 | (50) | (0.03) | ||||||||||
Adjusted | $ 218 | $ — | $ — | $ — | $ 16 | $ 1,330 | $ 302 | 22.7 % | $ 1,028 | $ 0.72 | |||||||||
Change - adjusted | 3.2 % | 4.6 % | 5.6 % | ||||||||||||||||
Impact of foreign currency | — % | (0.5) % | — % | ||||||||||||||||
Change - Constant currency adjusted | 3.2 % | 4.1 % | 5.6 % |
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||
RECONCILIATION OF CERTAIN FINANCIAL MEASURES BY SEGMENT TO CONSTANT CURRENCY | |||||
(UNAUDITED) | |||||
(in millions) | Reported | Items Affecting | Adjusted | ||
For the first six months of 2023: | |||||
Income from operations | |||||
$ 1,119 | $ 35 | $ 1,154 | |||
482 | 95 | 577 | |||
International | 192 | 8 | 200 | ||
Unallocated corporate costs | (440) | 81 | (359) | ||
Total income from operations | $ 1,353 | $ 219 | $ 1,572 | ||
For the first six months of 2022: | |||||
Income from operations | |||||
$ 1,232 | $ (230) | $ 1,002 | |||
550 | 93 | 643 | |||
International | 162 | 13 | 175 | ||
Unallocated corporate costs | (406) | 150 | (256) | ||
Total income from operations | $ 1,538 | $ 26 | $ 1,564 |
Reported | Impact of Foreign | Constant Currency | ||||
For the first six months of 2023: | ||||||
Net sales | ||||||
12.2 % | — % | 12.2 % | ||||
(3.6) | — | (3.6) | ||||
International | 13.7 | (2.4) | 11.3 | |||
Total net sales | 7.7 | (0.3) | 7.4 |
Adjusted | Impact of Foreign | Constant Currency | ||||
For the first six months of 2023: | ||||||
Income from operations | ||||||
15.2 % | — % | 15.2 % | ||||
(10.3) | — | (10.3) | ||||
International | 14.3 | (2.3) | 12.0 | |||
Total income from operations | 0.5 | (0.2) | 0.3 |
Reported | Items | Adjusted | Impact of | Constant | ||||||
For the first six months of 2023: | ||||||||||
Operating margin | ||||||||||
25.8 % | 0.8 % | 26.6 % | — % | 26.6 % | ||||||
25.4 | 5.0 | 30.4 | — | 30.4 | ||||||
International | 21.2 | 0.9 | 22.1 | — | 22.1 | |||||
Total operating margin | 18.9 | 3.1 | 22.0 | — | 22.0 |
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | |
RECONCILIATION OF ADJUSTED EBITDA AND MANAGEMENT LEVERAGE | |
(UNAUDITED) | |
(in millions, except for ratio) | |
ADJUSTED EBITDA RECONCILIATION - LAST TWELVE MONTHS | |
Net income attributable to KDP | $ 1,603 |
Interest expense | 525 |
Provision for income taxes | 333 |
Other (income) expense, net | (40) |
Depreciation expense | 395 |
Other amortization | 177 |
Amortization of intangibles | 140 |
EBITDA | $ 3,133 |
Items affecting comparability: | |
Impairment of intangible assets | $ 477 |
Restructuring and integration expenses | 114 |
Productivity | 225 |
Non-routine legal matters | 9 |
Stock compensation | 16 |
COVID-19 | 5 |
Foundational projects | 2 |
Mark to market | 99 |
Adjusted EBITDA | $ 4,080 |
June 30, | |
2023 | |
Principal amounts of: | |
Commercial paper notes | $ 988 |
Senior unsecured notes | 11,743 |
Total principal amounts | 12,731 |
Less: Cash and cash equivalents | 278 |
Total principal amounts less cash and cash equivalents | $ 12,453 |
June 30, 2023 Management Leverage Ratio | 3.1 |
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||||
RECONCILIATION OF ADJUSTED EBITDA - LAST TWELVE MONTHS | |||||||
(UNAUDITED) | |||||||
(in millions) | THIRD | FOURTH | FIRST SIX | LAST TWELVE | |||
Net income attributable to KDP | $ 180 | $ 453 | $ 970 | $ 1,603 | |||
Interest expense | 207 | 123 | 195 | 525 | |||
Provision for income taxes | 4 | 105 | 224 | 333 | |||
Other (income) expense, net | 4 | (8) | (36) | (40) | |||
Depreciation expense | 96 | 98 | 201 | 395 | |||
Other amortization | 43 | 43 | 91 | 177 | |||
Amortization of intangibles | 33 | 38 | 69 | 140 | |||
EBITDA | $ 567 | $ 852 | $ 1,714 | $ 3,133 | |||
Items affecting comparability: | |||||||
Impairment of intangible assets | $ 311 | $ 166 | $ — | $ 477 | |||
Restructuring and integration expenses | 33 | 81 | — | 114 | |||
Productivity | 50 | 64 | 111 | 225 | |||
Nonroutine legal matters | 2 | 4 | 3 | 9 | |||
Stock compensation | 5 | 2 | 9 | 16 | |||
COVID-19 | 5 | — | — | 5 | |||
Foundational projects | 1 | 1 | — | 2 | |||
Mark to market | 106 | (9) | 2 | 99 | |||
Adjusted EBITDA | $ 1,080 | $ 1,161 | $ 1,839 | $ 4,080 |
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC.
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW
(UNAUDITED)
Free cash flow is defined as net cash provided by operating activities adjusted for purchases of property, plant and equipment, proceeds from sales of property, plant and equipment, and certain items excluded for comparison to prior year periods. For the first six months of 2023 and 2022, there were no certain items excluded for comparison to prior year periods.
First Six Months | ||||
(in millions) | 2023 | 2022 | ||
Net cash provided by operating activities | $ 452 | $ 1,339 | ||
Purchases of property, plant and equipment | (149) | (186) | ||
Proceeds from sales of property, plant and equipment | 8 | 78 | ||
Free Cash Flow | $ 311 | $ 1,231 |
Diluted earnings per common share may not foot due to rounding. |
View original content to download multimedia:https://www.prnewswire.com/news-releases/keurig-dr-pepper-reports-q2-2023-results-raises-full-year-net-sales-outlook-and-reaffirms-eps-guidance-301886846.html
SOURCE Keurig Dr Pepper Inc.
FAQ
What were Keurig Dr Pepper's Q2 net sales?
What is Keurig Dr Pepper's full-year net sales outlook?